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A corrigendum on
Primary immunodeficiency diseases: an
update on the classification from the
International Union of Immunological
Societies Expert Committee for Primary
Immunodeficiency
by Al-Herz W, Bousfiha A, Casanova J-
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In Table 1 of the original manuscript, two
gene defects were inadvertently omitted.
These two defects (Cernunnos and DNA
ligase IV deficiency) fall into the category
of DNA recombination defects and lead
to a radiosensitive form of SCID associ-
ated with microcephaly and developmental
defects. These two genes have now been
added to a revised Table 1.
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Al-Herz et al. Correction to IUIS PID categorisation











1. T−B+ Severe combined immunodeficiency (SCID)
(a) γc deficiency Mutation of IL2RG
Defect in γ chain of receptors
for IL-2, -4, -7, -9, -15, -21








Defect in Janus activating
kinase 3








Defect in IL-7 receptor α chain
AR Markedly decreased Normal or
increased









Defect in CD3δ, chain of T cell
antigen receptor complex






Defect in CD3ε chain of T cell
antigen receptor complex






Defect in CD3ζ chain of T-cell
antigen receptor complex






Defective thymic egress of T
cells and defective T cell
locomotion











activating gene (RAG) 1








activating gene (RAG) 2








defect in Artemis DNA
recombinase-repair protein
AR Markedly decreased Markedly
decreased





defect in DNA PKcs;
Recombinase repair protein
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defect in DNA ligase IV
















































may lead to delayed or
milder presentation
102700




Defects in CD40 ligand



























Mutation of CD40 (also called








































Defect in CD3 γ-component of
the T cell antigen receptor
complex






Defects of CD8 α
chain – important for
maturation and function of
CD8 T cells







acts downstream of TCR
AR Decreased CD8,
normal CD4 cells
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9. MHC class I
deficiency
Mutations in TAP1, TAP2 or
TAPBP (tapasin) genes giving
MHC class I deficiency
AR Decreased CD8,
normal CD4






factors for MHC class II














Mutations in ITK encoding IL-2















encoding an adaptor protein
regulating intracellular signals





















Mutations in RMRP (RNase
MRP RNA) Involved in
processing of mitochondrial
RNA and cell cycle control





















impaired Mg++ flux leading to
impaired TCR signaling
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and impaired T cells
proliferation














Mutations in TRAC – essential
component of the T cell
receptor
AR Normal All CD3 T
cells expressed
TCRγδ (or may be













Defects in LCK – a proximal




















Mutations in MALT1 – a
caspase-like cysteine protease
that is essential for nuclear
factor-kappa-B activation











Defects in IL21R – together
with common gamma chain
binds IL-21
















Defects in UNC119 – an
activator of src tyrosine
kinases










Defects in CARD11 – acts as a


















Defects in OX40 – a co
stimulatory molecule
expressed on activated T cells
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Defects in IKBKB – encodes
IκB kinase 2, a component of
the NF-κB pathway
















Mutation in PIK3CD, PI3K-δ AD gain of
function
Decreased total

























AR Normal or decreased
















Mutations in CD27, encoding
TNF-R member superfamily
required for generation and
long-term maintenance of T
cell immunity


















RAG1, RAG2, Artemis, IL7RA,
RMRP, ADA, DNA Ligase IV,
IL2RG, AK2, or associated
with DiGeorge syndrome;















XL, X-linked inheritance; AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; SCID, severe combined immune deficiencies; EBV, Epstein–Barr
virus; Ca++, calcium; MHC, major histocompatibility complex, RTE, recent thymic emigrants, HPV, human papillomavirus.
aTen or fewer unrelated cases reported in the literature.
Infants with SCID who have maternal T cells engraftment may have T cells that do not function normally; these cells may cause autoimmune cytopenias or graft
versus host disease. Hypomorphic mutations in several of the genes that cause SCID may result in Omenn syndrome (OS), or “leaky” SCID or a less profound
CID phenotype. Both OS and leaky SCID can be associated with higher numbers of T cells and reduced rather than absent activation responses when compared
with typical SCID caused by null mutations. A spectrum of clinical findings including typical SCID, OS, leaky SCID, granulomas with T lymphopenia, autoimmunity,
and CD4+ T lymphopenia can be found with RAG gene defects. RAC2 deficiency is a disorder of leukocyte motility and is reported in Table 5; however, one patient
with RAC2 deficiency was found to have absent T cell receptor excision circles (TRECs) by newborn screening, but T cell numbers and mitogen responses were not
impaired. For additional syndromic conditions withT cell lymphopenia, such as DNA repair defects, cartilage hair hypoplasia, IKAROS deficiency, and NEMO syndrome,
see Table 2 and 6; however, it should be noted that individuals with the most severe manifestations of these disorders could have clinical signs and symptoms of
SCID. Severe folate deficiency (such as with malabsorption due to defects in folate carrier or transporter genes SLC10A1 or PCFT) and some metabolic disorders,
such as methylmalonic aciduria, may present with reversible profound lymphopenia in addition to their characteristic presenting features.
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